ARTEMISIA CINA PRE-FLOWERING TOP, TANACETUM VULGARE WHOLE, ARTEMISIA VULGARIS WHOLE, DRYOPTERIS FILIX-MAS ROOT, MERCURIC CHLORIDE, AND GRAPHITE

ARTEMISIA CINA PRE-FLOWERING TOP, TANACETUM VULGARE WHOLE, ARTEMISIA VULGARIS WHOLE, DRYOPTERIS FILIX-MAS ROOT, MERCURIC CHLORIDE, AND GRAPHITE was reported 1541 times

ARTEMISIA CINA PRE-FLOWERING TOP, TANACETUM VULGARE WHOLE, ARTEMISIA VULGARIS WHOLE, DRYOPTERIS FILIX-MAS ROOT, MERCURIC CHLORIDE, AND GRAPHITE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE HYPERTROPHY 1 0.0714
1 DIVERSION COLITIS 1 0.0303
2 BLOOD PRESSURE MANAGEMENT 1 0.0250
3 CLITORAL ENGORGEMENT 1 0.0250
4 EXERCISE ELECTROCARDIOGRAM ABNORMAL 1 0.0120
5 COELIAC ARTERY STENOSIS 1 0.0110
6 GINGIVAL ATROPHY 2 0.0102
7 ATROPHIC GLOSSITIS 1 0.0092
8 THUNDERCLAP HEADACHE 2 0.0076
9 ADMINISTRATION SITE IRRITATION 1 0.0071
10 BASOSQUAMOUS CARCINOMA 1 0.0067
11 EYELASH CHANGES 1 0.0056
12 EYELID SENSORY DISORDER 1 0.0051
13 DYSBACTERIOSIS 1 0.0047
14 BONE MARROW TRANSPLANT REJECTION 1 0.0045
15 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1 0.0043
16 CARDIAC PERFORATION 1 0.0043
17 ASPARTATE AMINOTRANSFERASE 1 0.0041
18 CHRONIC GASTROINTESTINAL BLEEDING 1 0.0039
19 COATING IN MOUTH 2 0.0037
20 EAR NEOPLASM 1 0.0036
21 OSTEOGENESIS IMPERFECTA 2 0.0034
22 BACTERIAL TEST 1 0.0034
23 BREAST INFLAMMATION 1 0.0032
24 FEMORAL ARTERY OCCLUSION 1 0.0032
25 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
26 FEMALE ORGASMIC DISORDER 1 0.0030
27 BLOOD TRIGLYCERIDES DECREASED 1 0.0030
28 INJECTION SITE MACULE 2 0.0029
29 ANDROGEN DEFICIENCY 1 0.0028
30 MYOFASCIAL PAIN SYNDROME 2 0.0028
31 TOE OPERATION 2 0.0025
32 ENDOCARDITIS BACTERIAL 2 0.0025
33 PHYSICAL PRODUCT LABEL ISSUE 3 0.0025
34 HEAT EXHAUSTION 2 0.0025
35 MITOCHONDRIAL TOXICITY 2 0.0024
36 CANDIDA TEST POSITIVE 1 0.0024
37 SENSATION OF PRESSURE 2 0.0023
38 GLYCOSURIA 3 0.0022
39 CHRONIC FATIGUE SYNDROME 3 0.0022
40 ENDOCARDITIS STAPHYLOCOCCAL 1 0.0020
41 CSF TEST ABNORMAL 1 0.0020
42 NON-ALCOHOLIC STEATOHEPATITIS 2 0.0019
43 PRODUCT COMMINGLING 2 0.0019
44 BLOOD IMMUNOGLOBULIN A INCREASED 1 0.0019
45 AUTOSCOPY 1 0.0019
46 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
47 EXECUTIVE DYSFUNCTION 1 0.0018
48 EJACULATION DELAYED 1 0.0018
49 BURN ORAL CAVITY 1 0.0017
50 DYSLEXIA 2 0.0017
51 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
52 DRUG MONITORING PROCEDURE NOT PERFORMED 3 0.0017
53 ATROPHY 3 0.0015
54 CELLULITIS STAPHYLOCOCCAL 1 0.0015
55 JOINT CREPITATION 3 0.0015
56 BLOOD OESTROGEN DECREASED 1 0.0014
57 FACIAL DISCOMFORT 1 0.0014
58 TEMPERATURE REGULATION DISORDER 3 0.0013
59 HYPOSMIA 2 0.0013
60 ARTERIAL RUPTURE 1 0.0013
61 DRUG TOLERANCE INCREASED 1 0.0013
62 BLISTER INFECTED 1 0.0013
63 AORTIC DISORDER 1 0.0013
64 COLON CANCER METASTATIC 2 0.0012
65 TENDON DISORDER 8 0.0012
66 FEAR OF FALLING 1 0.0012
67 BREAST OPERATION 1 0.0012
68 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
69 INJECTION RELATED REACTION 2 0.0012
70 DEPERSONALISATION 1 0.0012
71 COVID-19 IMMUNISATION 1 0.0012
72 VEIN RUPTURE 2 0.0012
73 TENDON PAIN 9 0.0012
74 MUSCLE FATIGUE 5 0.0012
75 ELECTRIC SHOCK 1 0.0012
76 CORONARY ARTERY DISSECTION 1 0.0012
77 ENTEROVIRUS INFECTION 1 0.0012
78 OTORRHOEA 2 0.0011
79 DRUG LEVEL FLUCTUATING 1 0.0011
80 WEIGHT BEARING DIFFICULTY 3 0.0011
81 APPARENT DEATH 4 0.0011
82 UTERINE SPASM 2 0.0011
83 COLOUR BLINDNESS 1 0.0011
84 DISTURBANCE IN SEXUAL AROUSAL 1 0.0011
85 LYMPH NODE PAIN 2 0.0011
86 CATHETER SITE SWELLING 1 0.0011
87 BUNDLE BRANCH BLOCK 1 0.0011
88 INTERVERTEBRAL DISCITIS 2 0.0011
89 ADRENAL DISORDER 2 0.0010
90 GINGIVAL RECESSION 2 0.0010
91 BLOOD URINE 1 0.0010
92 VOMITING PROJECTILE 3 0.0010
93 BONE SWELLING 1 0.0010
94 SENSATION OF HEAVINESS 4 0.0010
95 EYELID RASH 1 0.0010
96 HYPOGEUSIA 2 0.0010
97 DACTYLITIS 1 0.0010
98 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 1 0.0009
99 VITREOUS DETACHMENT 2 0.0009
100 REACTION TO DRUG EXCIPIENTS 2 0.0009
101 TONGUE DISCOLOURATION 4 0.0009
102 PRODUCT FORMULATION ISSUE 6 0.0009
103 CYSTIC FIBROSIS 5 0.0009
104 INJECTION SITE PAPULE 4 0.0009
105 CHEMICAL BURN 1 0.0009
106 FOLATE DEFICIENCY 1 0.0009
107 MUSCLE DISORDER 7 0.0009
108 ALLODYNIA 1 0.0009
109 URINARY TRACT OBSTRUCTION 2 0.0008
110 SINUS OPERATION 2 0.0008
111 BLADDER PROLAPSE 1 0.0008
112 BLADDER DISCOMFORT 1 0.0008
113 APPLICATION SITE SCAR 1 0.0008
114 IMPAIRED WORK ABILITY 17 0.0008
115 APPLICATION SITE WARMTH 1 0.0008
116 FACIAL PAIN 7 0.0008
117 TENDONITIS 12 0.0008
118 CALCIUM DEFICIENCY 1 0.0008
119 FOREIGN BODY IN RESPIRATORY TRACT 1 0.0008
120 CARDIOACTIVE DRUG LEVEL INCREASED 1 0.0008
121 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
122 PRODUCT SUBSTITUTION ISSUE 43 0.0007
123 QUALITY OF LIFE DECREASED 10 0.0007
124 SKIN DISCOMFORT 2 0.0007
125 ANORGASMIA 2 0.0007
126 MIGRAINE WITH AURA 2 0.0007
127 SKIN WRINKLING 2 0.0007
128 AGORAPHOBIA 1 0.0007
129 ABSCESS ORAL 1 0.0007
130 BILIARY TRACT DISORDER 1 0.0007
131 TRICHORRHEXIS 2 0.0007
132 HYPERTONIC BLADDER 2 0.0007
133 SKIN WARM 4 0.0007
134 DARK CIRCLES UNDER EYES 1 0.0007
135 GINGIVAL SWELLING 3 0.0007
136 MUSCLE TIGHTNESS 11 0.0007
137 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
138 EXCESSIVE EYE BLINKING 1 0.0007
139 FEELING DRUNK 5 0.0007
140 ADHESION 1 0.0007
141 ASTIGMATISM 1 0.0007
142 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
143 CALCULUS URINARY 1 0.0006
144 BACTERIAL VAGINOSIS 1 0.0006
145 PHOTOPSIA 4 0.0006
146 CHRONIC LYMPHOCYTIC LEUKAEMIA 3 0.0006
147 CYSTITIS INTERSTITIAL 1 0.0006
148 AORTIC VALVE DISEASE 1 0.0006
149 ABNORMAL FAECES 5 0.0006
150 BLOOD CALCIUM ABNORMAL 1 0.0006
151 VEIN DISORDER 3 0.0006
152 INTERNATIONAL NORMALISED RATIO ABNORMAL 2 0.0006
153 EMOTIONAL POVERTY 1 0.0006
154 POLYARTHRITIS 3 0.0006
155 SCIATICA 9 0.0006
156 STRESS FRACTURE 3 0.0006
157 ACTIVITIES OF DAILY LIVING IMPAIRED 11 0.0006
158 CHEILITIS 3 0.0006
159 DEVICE ALARM ISSUE 1 0.0006
160 ESSENTIAL HYPERTENSION 1 0.0005
161 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
162 PARADOXICAL DRUG REACTION 2 0.0005
163 BLINDNESS TRANSIENT 4 0.0005
164 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
165 HYPERACUSIS 2 0.0005
166 AURA 1 0.0005
167 THROAT CLEARING 2 0.0005
168 BLOOD IRON INCREASED 1 0.0005
169 BEDRIDDEN 7 0.0005
170 SPINAL DISORDER 5 0.0005
171 LOSS OF CONTROL OF LEGS 2 0.0005
172 CLAVICLE FRACTURE 2 0.0005
173 EXERCISE TOLERANCE DECREASED 3 0.0005
174 MUSCLE TWITCHING 12 0.0005
175 GINGIVAL DISORDER 2 0.0005
176 MOUTH SWELLING 3 0.0005
177 FAECES HARD 2 0.0005
178 OESOPHAGEAL PAIN 2 0.0005
179 GINGIVAL PAIN 4 0.0005
180 FOREIGN BODY 2 0.0005
181 ENURESIS 2 0.0005
182 VITAMIN B12 DEFICIENCY 2 0.0005
183 EYELID PAIN 1 0.0005
184 DERMATITIS PSORIASIFORM 1 0.0005
185 GOITRE 2 0.0005
186 HYPERAESTHESIA 4 0.0005
187 SOCIAL PROBLEM 2 0.0005
188 THINKING ABNORMAL 9 0.0005
189 BODY TEMPERATURE FLUCTUATION 1 0.0005
190 ONYCHOMADESIS 2 0.0005
191 EYE CONTUSION 1 0.0005
192 CARDIAC OPERATION 4 0.0005
193 BLOOD TESTOSTERONE INCREASED 1 0.0005
194 DEREALISATION 1 0.0005
195 HYPOAESTHESIA ORAL 7 0.0005
196 MONOPLEGIA 2 0.0005
197 LOCAL SWELLING 8 0.0005
198 DYSPHEMIA 2 0.0005
199 CORNEAL DISORDER 1 0.0005
200 GROIN PAIN 4 0.0005
201 DYSGRAPHIA 3 0.0005
202 CLOSTRIDIUM TEST POSITIVE 1 0.0005
203 NEURALGIA 11 0.0005
204 DANDRUFF 1 0.0005
205 BLOOD CREATINE INCREASED 2 0.0005
206 FAECES PALE 1 0.0004
207 CALCINOSIS 1 0.0004
208 PRODUCT LABEL ISSUE 3 0.0004
209 URINE ABNORMALITY 2 0.0004
210 IMPAIRED DRIVING ABILITY 5 0.0004
211 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
212 MUSCULOSKELETAL PAIN 23 0.0004
213 SCAB 5 0.0004
214 MOVEMENT DISORDER 14 0.0004
215 LYMPHOEDEMA 3 0.0004
216 EYELID DISORDER 1 0.0004
217 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
218 BREAKTHROUGH PAIN 1 0.0004
219 DEFAECATION URGENCY 3 0.0004
220 DISCOURAGEMENT 1 0.0004
221 VAGINAL INFECTION 2 0.0004
222 PHOTOSENSITIVITY REACTION 7 0.0004
223 COLITIS MICROSCOPIC 2 0.0004
224 EMOTIONAL DISORDER 13 0.0004
225 BLOOD IRON DECREASED 5 0.0004
226 PARALYSIS 6 0.0004
227 DIABETES INSIPIDUS 1 0.0004
228 VULVOVAGINAL PAIN 2 0.0004
229 DIZZINESS POSTURAL 4 0.0004
230 ORAL DISORDER 3 0.0004
231 DERMAL CYST 1 0.0004
232 THERAPY CHANGE 4 0.0004
233 TENDON RUPTURE 5 0.0004
234 ABASIA 10 0.0004
235 DEVICE INFUSION ISSUE 1 0.0004
236 BLADDER DISORDER 4 0.0004
237 APPLICATION SITE SWELLING 2 0.0004
238 AGEUSIA 10 0.0004
239 BREAST TENDERNESS 3 0.0004
240 PAROSMIA 3 0.0004
241 EXPOSURE VIA INGESTION 1 0.0004
242 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
243 ECONOMIC PROBLEM 6 0.0004
244 FEEDING DISORDER 8 0.0004
245 DRY THROAT 4 0.0004
246 EAR DISCOMFORT 4 0.0004
247 BLOOD CHLORIDE DECREASED 1 0.0004
248 APHTHOUS ULCER 3 0.0004
249 POOR VENOUS ACCESS 4 0.0004
250 FOOD CRAVING 2 0.0004
251 INCONTINENCE 4 0.0004
252 NASAL DISCOMFORT 3 0.0004
253 ANIMAL BITE 1 0.0004
254 BODY HEIGHT DECREASED 4 0.0004
255 MIOSIS 3 0.0004
256 BRUXISM 2 0.0004
257 GINGIVITIS 2 0.0004
258 DECREASED ACTIVITY 4 0.0004
259 TINNITUS 17 0.0004
260 PRURITUS GENERALISED 8 0.0004
261 HIP SURGERY 2 0.0004
262 CHONDROPATHY 1 0.0004
263 ABDOMINAL RIGIDITY 1 0.0004
264 POLYURIA 3 0.0004
265 PERIPHERAL COLDNESS 5 0.0004
266 ASTHENOPIA 2 0.0004
267 GASTROINTESTINAL PAIN 4 0.0004
268 TOOTH FRACTURE 4 0.0004
269 HYPERKERATOSIS 2 0.0004
270 STREPTOCOCCAL INFECTION 2 0.0004
271 COORDINATION ABNORMAL 5 0.0004
272 MASS 5 0.0004
273 REBOUND EFFECT 4 0.0004
274 CHOLECYSTITIS ACUTE 2 0.0004
275 DIPLOPIA 9 0.0003
276 EYELID MARGIN CRUSTING 1 0.0003
277 ANOSMIA 5 0.0003
278 PRODUCT LABEL CONFUSION 2 0.0003
279 DYSSTASIA 10 0.0003
280 BURNING SENSATION 24 0.0003
281 NECK PAIN 19 0.0003
282 DECREASED INTEREST 2 0.0003
283 ODYNOPHAGIA 2 0.0003
284 ACCIDENT 4 0.0003
285 TOOTHACHE 6 0.0003
286 THERAPY CESSATION 17 0.0003
287 EYE INJURY 1 0.0003
288 RETCHING 7 0.0003
289 OVARIAN CANCER 3 0.0003
290 BLOOD GLUCOSE ABNORMAL 6 0.0003
291 PALPITATIONS 38 0.0003
292 DIASTOLIC DYSFUNCTION 1 0.0003
293 MYALGIA 55 0.0003
294 FAMILY STRESS 1 0.0003
295 COGNITIVE DISORDER 15 0.0003
296 EYELIDS PRURITUS 1 0.0003
297 SECRETION DISCHARGE 4 0.0003
298 SWELLING OF EYELID 2 0.0003
299 NIGHTMARE 11 0.0003
300 BLEPHAROSPASM 2 0.0003
301 MUSCULAR WEAKNESS 36 0.0003
302 DRUG EFFECT INCREASED 1 0.0003
303 THERAPEUTIC RESPONSE CHANGED 2 0.0003
304 BLADDER PAIN 1 0.0003
305 EXPOSURE TO TOXIC AGENT 1 0.0003
306 ORAL PAIN 7 0.0003
307 POLLAKIURIA 13 0.0003
308 SENSORY DISTURBANCE 5 0.0003
309 CARDIAC FLUTTER 2 0.0003
310 VITAMIN D DEFICIENCY 3 0.0003
311 BACTERIAL SEPSIS 1 0.0003
312 POLYP 2 0.0003
313 BREAST ENLARGEMENT 1 0.0003
314 VITREOUS FLOATERS 3 0.0003
315 PULMONARY CONGESTION 4 0.0003
316 INABILITY TO AFFORD MEDICATION 3 0.0003
317 SKIN DISORDER 10 0.0003
318 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
319 CHILLS 35 0.0003
320 JOINT RANGE OF MOTION DECREASED 4 0.0003
321 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
322 FEELING HOT 18 0.0003
323 EUPHORIC MOOD 3 0.0003
324 BLOOD TESTOSTERONE DECREASED 2 0.0003
325 INJECTION SITE WARMTH 6 0.0003
326 ONYCHOCLASIS 2 0.0003
327 ABNORMAL DREAMS 8 0.0003
328 LARGE INTESTINE POLYP 2 0.0003
329 FIBROMYALGIA 7 0.0003
330 AORTIC STENOSIS 1 0.0003
331 PRODUCT ODOUR ABNORMAL 3 0.0003
332 CAROTID ARTERY STENOSIS 1 0.0003
333 INJECTION SITE URTICARIA 7 0.0003
334 EAR PRURITUS 1 0.0003
335 SCRATCH 3 0.0003
336 PAPULE 2 0.0003
337 GAIT DISTURBANCE 54 0.0003
338 NIGHT SWEATS 9 0.0003
339 PANIC REACTION 2 0.0003
340 PULMONARY THROMBOSIS 3 0.0003
341 FAECES SOFT 2 0.0003
342 BONE DISORDER 5 0.0003
343 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
344 BLOOD PHOSPHORUS DECREASED 1 0.0003
345 DYSPHONIA 16 0.0003
346 DENTAL CARIES 3 0.0003
347 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
348 HYPOPHOSPHATAEMIA 2 0.0003
349 ARTHROPOD BITE 2 0.0003
350 TOOTH DISORDER 6 0.0003
351 NERVE INJURY 3 0.0003
352 MEMORY IMPAIRMENT 37 0.0003
353 EYE SWELLING 10 0.0003
354 GLOSSODYNIA 6 0.0003
355 MIDDLE INSOMNIA 5 0.0003
356 JOINT STIFFNESS 7 0.0003
357 ANGER 9 0.0003
358 BLOOD PRESSURE INCREASED 40 0.0003
359 INSURANCE ISSUE 4 0.0003
360 COMMUNICATION DISORDER 1 0.0003
361 DISSOCIATION 2 0.0003
362 FEAR 7 0.0003
363 PAIN OF SKIN 7 0.0003
364 FOOD ALLERGY 2 0.0003
365 EAR PAIN 5 0.0003
366 PELVIC FRACTURE 2 0.0003
367 CARDIOPULMONARY FAILURE 1 0.0003
368 NERVOUS SYSTEM DISORDER 8 0.0003
369 CHOKING 5 0.0003
370 ORAL HERPES 5 0.0003
371 EPIGASTRIC DISCOMFORT 1 0.0003
372 CERVIX CARCINOMA 1 0.0003
373 FLUSHING 26 0.0003
374 BRAIN FOG 4 0.0003
375 DIVERTICULITIS 7 0.0003
376 MACULAR DEGENERATION 3 0.0003
377 PAIN IN EXTREMITY 74 0.0003
378 CEREBRAL ATROPHY 1 0.0003
379 BLOOD DISORDER 2 0.0002
380 EYE PAIN 14 0.0002
381 RHINITIS 2 0.0002
382 MENTAL IMPAIRMENT 6 0.0002
383 HYPOAESTHESIA 37 0.0002
384 TREMOR 41 0.0002
385 PANIC ATTACK 9 0.0002
386 TASTE DISORDER 5 0.0002
387 APPLICATION SITE DISCOLOURATION 1 0.0002
388 AMNESIA 16 0.0002
389 DEMYELINATION 1 0.0002
390 ARTHRITIS BACTERIAL 1 0.0002
391 ESCHERICHIA INFECTION 2 0.0002
392 BALANCE DISORDER 21 0.0002
393 APPLICATION SITE EXFOLIATION 1 0.0002
394 CYST 3 0.0002
395 DISTURBANCE IN ATTENTION 13 0.0002
396 MIGRAINE 23 0.0002
397 GAIT INABILITY 8 0.0002
398 BONE PAIN 14 0.0002
399 DERMATITIS ALLERGIC 3 0.0002
400 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
401 MUSCLE ATROPHY 3 0.0002
402 BUNDLE BRANCH BLOCK LEFT 1 0.0002
403 INADEQUATE ANALGESIA 2 0.0002
404 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
405 ABSCESS LIMB 1 0.0002
406 ALCOHOLISM 1 0.0002
407 ROTATOR CUFF SYNDROME 3 0.0002
408 PSEUDOMONAS INFECTION 2 0.0002
409 IRRITABLE BOWEL SYNDROME 5 0.0002
410 PARANOIA 4 0.0002
411 LACRIMATION INCREASED 7 0.0002
412 HIATUS HERNIA 3 0.0002
413 NEUROPATHY PERIPHERAL 22 0.0002
414 MUSCLE STRAIN 2 0.0002
415 RASH ERYTHEMATOUS 11 0.0002
416 BONE CANCER 1 0.0002
417 MUSCLE SPASMS 42 0.0002
418 RASH MACULAR 8 0.0002
419 URINE OUTPUT DECREASED 2 0.0002
420 HEART RATE DECREASED 8 0.0002
421 SPINAL OSTEOARTHRITIS 2 0.0002
422 ANKYLOSING SPONDYLITIS 3 0.0002
423 ABDOMINAL ABSCESS 1 0.0002
424 ADVERSE REACTION 3 0.0002
425 VISION BLURRED 31 0.0002
426 CATHETERISATION CARDIAC 1 0.0002
427 BACK PAIN 52 0.0002
428 THROAT IRRITATION 10 0.0002
429 DRUG EFFECT DECREASED 12 0.0002
430 PARAESTHESIA 35 0.0002
431 LOSS OF LIBIDO 2 0.0002
432 THROAT TIGHTNESS 6 0.0002
433 INSOMNIA 59 0.0002
434 UVEITIS 3 0.0002
435 LIMB INJURY 6 0.0002
436 DRUG EFFECT DELAYED 1 0.0002
437 LUPUS-LIKE SYNDROME 2 0.0002
438 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
439 CRYING 8 0.0002
440 ABDOMINAL HERNIA 1 0.0002
441 DIZZINESS 109 0.0002
442 DISEASE COMPLICATION 1 0.0002
443 EAR DISORDER 1 0.0002
444 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
445 BRAIN NEOPLASM 2 0.0002
446 SKIN DISCOLOURATION 10 0.0002
447 INCREASED TENDENCY TO BRUISE 2 0.0002
448 HYPERHIDROSIS 28 0.0002
449 DYSURIA 8 0.0002
450 HYPOMAGNESAEMIA 3 0.0002
451 SWELLING FACE 14 0.0002
452 APHONIA 3 0.0002
453 CHEST DISCOMFORT 22 0.0002
454 SINUSITIS 22 0.0002
455 FEELING OF DESPAIR 1 0.0002
456 BACTERIAL INFECTION 4 0.0002
457 CARPAL TUNNEL SYNDROME 3 0.0002
458 BLOOD TEST ABNORMAL 3 0.0002
459 FLANK PAIN 2 0.0002
460 INJECTION SITE BRUISING 17 0.0002
461 EYE DISORDER 7 0.0002
462 LACERATION 2 0.0002
463 SLEEP DISORDER 15 0.0002
464 LEUKAEMIA 2 0.0002
465 PAIN IN JAW 6 0.0002
466 ARTHRALGIA 88 0.0002
467 FLATULENCE 12 0.0002
468 OCULAR HYPERAEMIA 10 0.0002
469 MUSCULOSKELETAL DISORDER 4 0.0002
470 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
471 DRY MOUTH 17 0.0002
472 FAECAL INCONTINENCE 1 0.0002
473 AFFECT LABILITY 2 0.0002
474 APHAGIA 1 0.0002
475 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
476 INFLUENZA LIKE ILLNESS 17 0.0002
477 PHARYNGEAL SWELLING 2 0.0002
478 MENORRHAGIA 4 0.0002
479 APPLICATION SITE BURN 1 0.0002
480 DIABETIC NEUROPATHY 1 0.0002
481 BLOOD PRESSURE ABNORMAL 4 0.0002
482 ANEURYSM 1 0.0002
483 HYPOTONIA 2 0.0002
484 DRY EYE 10 0.0002
485 DYSPHAGIA 19 0.0002
486 FLUID INTAKE REDUCED 1 0.0002
487 APHASIA 6 0.0002
488 DRUG TOLERANCE 1 0.0002
489 CONTUSION 19 0.0002
490 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
491 PHARYNGEAL OEDEMA 3 0.0002
492 INITIAL INSOMNIA 2 0.0002
493 RIB FRACTURE 4 0.0002
494 MUSCULOSKELETAL STIFFNESS 17 0.0002
495 TEMPERATURE INTOLERANCE 2 0.0002
496 INJECTION SITE ERYTHEMA 24 0.0002
497 RASH GENERALISED 5 0.0002
498 BLOOD CHOLESTEROL INCREASED 9 0.0002
499 TOOTH LOSS 4 0.0002
500 BASAL CELL CARCINOMA 3 0.0002
501 TENDERNESS 2 0.0002
502 WEIGHT FLUCTUATION 2 0.0002
503 SPEECH DISORDER 10 0.0002
504 CYANOSIS 3 0.0002
505 ANXIETY 54 0.0002
506 HALLUCINATION, VISUAL 4 0.0002
507 OSTEOARTHRITIS 8 0.0002
508 DYSGEUSIA 14 0.0002
509 ANORECTAL DISCOMFORT 1 0.0002
510 FEELING ABNORMAL 45 0.0002
511 DRUG DOSE OMISSION 31 0.0002
512 POOR QUALITY SLEEP 4 0.0002
513 ERYTHEMA OF EYELID 1 0.0002
514 FAECES DISCOLOURED 4 0.0002
515 BACK INJURY 2 0.0002
516 MOOD ALTERED 5 0.0002
517 IRRITABILITY 11 0.0002
518 INJECTION SITE SWELLING 14 0.0002
519 WOUND INFECTION 2 0.0002
520 STAPHYLOCOCCAL INFECTION 6 0.0002
521 PERIPHERAL SWELLING 28 0.0002
522 INJECTION SITE NODULE 2 0.0002
523 CHOKING SENSATION 1 0.0002
524 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
525 VISUAL ACUITY REDUCED 6 0.0002
526 VERTIGO 11 0.0002
527 FOOT DEFORMITY 2 0.0002
528 FUNGAL INFECTION 6 0.0002
529 URINARY RETENTION 6 0.0002
530 FATIGUE 140 0.0002
531 INJECTION SITE PRURITUS 12 0.0002
532 URTICARIA 30 0.0002
533 DEMENTIA 5 0.0002
534 BLISTER 10 0.0002
535 SKIN EXFOLIATION 15 0.0002
536 CANDIDA INFECTION 3 0.0002
537 PRURITUS 68 0.0002
538 MITRAL VALVE INCOMPETENCE 2 0.0002
539 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
540 APPLICATION SITE PRURITUS 4 0.0002
541 URINARY TRACT INFECTION 30 0.0002
542 PRODUCT AVAILABILITY ISSUE 4 0.0002
543 ASTHENIA 66 0.0002
544 DERMATITIS CONTACT 2 0.0002
545 ERYTHEMA 36 0.0002
546 CARDIAC VALVE DISEASE 1 0.0002
547 ANGINA PECTORIS 5 0.0002
548 MUSCULOSKELETAL DISCOMFORT 3 0.0002
549 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
550 BLOOD URIC ACID INCREASED 1 0.0002
551 METASTASES TO LUNG 2 0.0002
552 OROPHARYNGEAL PAIN 16 0.0002
553 MADAROSIS 2 0.0002
554 POST PROCEDURAL HAEMORRHAGE 2 0.0002
555 HEART RATE INCREASED 17 0.0002
556 SPINAL PAIN 2 0.0002
557 METASTASES TO LIVER 3 0.0002
558 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
559 COLD SWEAT 3 0.0002
560 NASAL CONGESTION 10 0.0002
561 CATARACT OPERATION 1 0.0002
562 THIRST 3 0.0002
563 HYPERLIPIDAEMIA 2 0.0002
564 MUSCLE RIGIDITY 2 0.0002
565 GOUT 3 0.0002
566 BLOOD GLUCOSE DECREASED 8 0.0002
567 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
568 INJECTION SITE PAIN 51 0.0002
569 GASTROENTERITIS VIRAL 3 0.0002
570 RASH PRURITIC 9 0.0002
571 LOCALISED INFECTION 4 0.0002
572 ARTHRITIS 13 0.0002
573 STOMATITIS 10 0.0002
574 NOCTURIA 2 0.0002
575 NO THERAPEUTIC RESPONSE 2 0.0002
576 RESTLESSNESS 6 0.0002
577 PAIN 100 0.0002
578 DYSPEPSIA 16 0.0002
579 HYPERCALCAEMIA 2 0.0002
580 LIMB DISCOMFORT 5 0.0002
581 CHOLANGITIS 1 0.0002
582 PHARYNGITIS 2 0.0002
583 HEADACHE 101 0.0002
584 ILEUS 2 0.0002
585 INJECTION SITE DISCOLOURATION 2 0.0002
586 SYNCOPE 16 0.0002
587 HEPATIC CIRRHOSIS 3 0.0002
588 DYSARTHRIA 6 0.0002
589 HYPOCALCAEMIA 3 0.0002
590 DEPRESSION 36 0.0002
591 ABDOMINAL PAIN LOWER 4 0.0002
592 JOINT SWELLING 19 0.0002
593 CYSTITIS 5 0.0002
594 LOWER LIMB FRACTURE 3 0.0002
595 MYDRIASIS 2 0.0002
596 ERECTILE DYSFUNCTION 4 0.0002
597 ERUCTATION 3 0.0002
598 APPLICATION SITE VESICLES 1 0.0002
599 NAUSEA 122 0.0002
600 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
601 NERVOUSNESS 8 0.0002
602 BRADYPHRENIA 1 0.0002
603 DEAFNESS 4 0.0002
604 SUICIDAL IDEATION 14 0.0002
605 INCORRECT PRODUCT STORAGE 2 0.0002
606 IMMUNE SYSTEM DISORDER 2 0.0002
607 TOOTH INFECTION 2 0.0002
608 CONSTIPATION 33 0.0002
609 HAEMATOCRIT DECREASED 3 0.0002
610 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
611 DIARRHOEA 97 0.0002
612 RENAL DISORDER 7 0.0002
613 LIP SWELLING 5 0.0001
614 HAIR TEXTURE ABNORMAL 2 0.0001
615 ABDOMINAL DISCOMFORT 25 0.0001
616 PRODUCT PHYSICAL ISSUE 3 0.0001
617 TYPE 2 DIABETES MELLITUS 5 0.0001
618 COLITIS ISCHAEMIC 1 0.0001
619 SINUS CONGESTION 2 0.0001
620 DYSKINESIA 6 0.0001
621 DISCOMFORT 9 0.0001
622 BODY TEMPERATURE INCREASED 3 0.0001
623 IMPAIRED GASTRIC EMPTYING 2 0.0001
624 PRODUCTIVE COUGH 7 0.0001
625 GINGIVAL BLEEDING 2 0.0001
626 DECREASED APPETITE 34 0.0001
627 EYE MOVEMENT DISORDER 1 0.0001
628 HOT FLUSH 11 0.0001
629 CROHN'S DISEASE 1 0.0001
630 ECCHYMOSIS 1 0.0001
631 ABDOMINAL PAIN UPPER 30 0.0001
632 GASTRIC DISORDER 5 0.0001
633 INJECTION SITE REACTION 10 0.0001
634 HAEMATOCHEZIA 8 0.0001
635 ENCEPHALITIS 1 0.0001
636 FALL 48 0.0001
637 MENTAL STATUS CHANGES 4 0.0001
638 SOMNOLENCE 29 0.0001
639 ARTHROPATHY 8 0.0001
640 ORAL DISCOMFORT 2 0.0001
641 AUTOIMMUNE HEPATITIS 1 0.0001
642 FORMICATION 1 0.0001
643 INTENTIONAL DRUG MISUSE 3 0.0001
644 ROAD TRAFFIC ACCIDENT 6 0.0001
645 HAEMOPTYSIS 4 0.0001
646 EXTRASYSTOLES 1 0.0001
647 WITHDRAWAL SYNDROME 6 0.0001
648 DEHYDRATION 19 0.0001
649 APPLICATION SITE REACTION 1 0.0001
650 BLINDNESS UNILATERAL 2 0.0001
651 SEASONAL ALLERGY 2 0.0001
652 LYMPHADENOPATHY 5 0.0001
653 DIVERTICULUM 1 0.0001
654 JOINT INJURY 3 0.0001
655 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
656 HYPERSOMNIA 4 0.0001
657 MOBILITY DECREASED 10 0.0001
658 PARAESTHESIA ORAL 2 0.0001
659 DYSPNOEA 77 0.0001
660 CHEST PAIN 25 0.0001
661 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
662 WHEEZING 8 0.0001
663 VOMITING 63 0.0001
664 WEIGHT INCREASED 30 0.0001
665 RESPIRATORY DISORDER 4 0.0001
666 EPISTAXIS 10 0.0001
667 CHROMATURIA 3 0.0001
668 HEART RATE IRREGULAR 3 0.0001
669 HALLUCINATION 10 0.0001
670 LOSS OF CONSCIOUSNESS 17 0.0001
671 PRODUCT QUALITY ISSUE 18 0.0001
672 UNEVALUABLE EVENT 10 0.0001
673 COUGH 37 0.0001
674 BLOOD COUNT ABNORMAL 2 0.0001
675 OSTEOPENIA 2 0.0001
676 SKIN IRRITATION 6 0.0001
677 NEPHROLITHIASIS 6 0.0001
678 BOWEL MOVEMENT IRREGULARITY 1 0.0001
679 HYPOKALAEMIA 6 0.0001
680 THYROID DISORDER 2 0.0001
681 ATRIOVENTRICULAR BLOCK 1 0.0001
682 MUSCULOSKELETAL CHEST PAIN 2 0.0001
683 VISUAL IMPAIRMENT 16 0.0001
684 RASH 56 0.0001
685 APNOEA 1 0.0001
686 SWELLING 12 0.0001
687 AFFECTIVE DISORDER 1 0.0001
688 PRODUCT USE COMPLAINT 2 0.0001
689 HEAD INJURY 4 0.0001
690 DISORIENTATION 5 0.0001
691 DISEASE RECURRENCE 6 0.0001
692 MOOD SWINGS 4 0.0001
693 ATRIAL FLUTTER 1 0.0001
694 HYPOTHYROIDISM 4 0.0001
695 INJECTION SITE HAEMORRHAGE 10 0.0001
696 BLOOD PRESSURE FLUCTUATION 3 0.0001
697 DIABETIC KETOACIDOSIS 3 0.0001
698 ABDOMINAL DISTENSION 13 0.0001
699 HIP FRACTURE 4 0.0001
700 RHINORRHOEA 8 0.0001
701 FRUSTRATION TOLERANCE DECREASED 1 0.0001
702 CONFUSIONAL STATE 20 0.0001
703 BACK DISORDER 2 0.0001
704 ASPHYXIA 1 0.0001
705 ALOPECIA 24 0.0001
706 HERPES ZOSTER 7 0.0001
707 OSTEOPOROSIS 5 0.0001
708 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
709 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
710 BREAST CANCER STAGE II 1 0.0001
711 COAGULOPATHY 2 0.0001
712 EOSINOPHIL COUNT INCREASED 1 0.0001
713 DRY SKIN 16 0.0001
714 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
715 FACE OEDEMA 2 0.0001
716 MALAISE 52 0.0001
717 HAEMATEMESIS 3 0.0001
718 RENAL FAILURE ACUTE 5 0.0001
719 FACIAL PARALYSIS 1 0.0001
720 SCAR 2 0.0001
721 ANAPHYLACTIC SHOCK 3 0.0001
722 INFLAMMATION 6 0.0001
723 CARDIAC MURMUR 1 0.0001
724 MENTAL DISORDER 5 0.0001
725 APPLICATION SITE ERYTHEMA 3 0.0001
726 DRUG WITHDRAWAL SYNDROME 10 0.0001
727 DEVICE MALFUNCTION 8 0.0001
728 HEAD DISCOMFORT 2 0.0001
729 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
730 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
731 GALLBLADDER DISORDER 2 0.0001
732 GASTROINTESTINAL DISORDER 10 0.0001
733 FREQUENT BOWEL MOVEMENTS 3 0.0001
734 WEIGHT DECREASED 31 0.0001
735 PALLOR 3 0.0001
736 PELVIC PAIN 2 0.0001
737 SKIN LESION 3 0.0001
738 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
739 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
740 HYPERTENSION 23 0.0001
741 BRONCHITIS 8 0.0001
742 FEELING COLD 3 0.0001
743 HEPATIC STEATOSIS 2 0.0001
744 RENAL IMPAIRMENT 9 0.0001
745 DEFORMITY 1 0.0001
746 CARDIAC DISORDER 10 0.0001
747 TARDIVE DYSKINESIA 3 0.0001
748 PHOTOPHOBIA 2 0.0001
749 BLOOD SODIUM DECREASED 2 0.0001
750 RHEUMATOID ARTHRITIS 12 0.0001
751 BLOOD URINE PRESENT 2 0.0001
752 GASTRIC ULCER 2 0.0001
753 FEELING JITTERY 2 0.0001
754 RED BLOOD CELL COUNT DECREASED 3 0.0001
755 SLEEP APNOEA SYNDROME 2 0.0001
756 MULTIPLE SCLEROSIS 5 0.0001
757 PULMONARY FIBROSIS 2 0.0001
758 EYE IRRITATION 6 0.0001
759 PYREXIA 36 0.0001
760 HYPOGLYCAEMIA 5 0.0001
761 HEPATIC ENZYME INCREASED 7 0.0001
762 AUTOIMMUNE DISORDER 1 0.0001
763 SURGERY 6 0.0001
764 KIDNEY INFECTION 2 0.0001
765 BODY TEMPERATURE DECREASED 1 0.0001
766 DISABILITY 2 0.0001
767 SINUS DISORDER 2 0.0001
768 PRESCRIBED UNDERDOSE 2 0.0001
769 AGGRESSION 5 0.0001
770 BLOOD POTASSIUM DECREASED 3 0.0001
771 BRAIN INJURY 1 0.0001
772 THROMBOSIS 8 0.0001
773 EMPHYSEMA 1 0.0001
774 OEDEMA PERIPHERAL 12 0.0001
775 EYELID PTOSIS 1 0.0001
776 INJURY ASSOCIATED WITH DEVICE 2 0.0001
777 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
778 SKIN BURNING SENSATION 7 0.0001
779 ASTHMA 11 0.0001
780 LUNG NEOPLASM MALIGNANT 4 0.0001
781 FEMUR FRACTURE 3 0.0001
782 EYE DISCHARGE 1 0.0001
783 SWOLLEN TONGUE 3 0.0001
784 CARDIO-RESPIRATORY ARREST 4 0.0001
785 ECZEMA 5 0.0001
786 CONDITION AGGRAVATED 29 0.0001
787 FOLLICULITIS 1 0.0001
788 AGITATION 7 0.0001
789 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
790 ABDOMINAL PAIN 22 0.0001
791 EATING DISORDER 2 0.0001
792 BREAST PAIN 1 0.0001
793 LIVER FUNCTION TEST INCREASED 2 0.0001
794 BREAST CANCER METASTATIC 1 0.0001
795 RECTAL HAEMORRHAGE 4 0.0001
796 ATRIAL FIBRILLATION 9 0.0001
797 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
798 NASOPHARYNGITIS 17 0.0001
799 OEDEMA 5 0.0001
800 BIPOLAR DISORDER 1 0.0001
801 DIABETES MELLITUS 7 0.0001
802 PRODUCT PRESCRIBING ISSUE 2 0.0001
803 HYPERSENSITIVITY 17 0.0001
804 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
805 INTENTIONAL PRODUCT MISUSE 8 0.0001
806 OSTEONECROSIS 3 0.0001
807 ASPIRATION 1 0.0001
808 BLOOD GLUCOSE FLUCTUATION 1 0.0001
809 APPLICATION SITE PAIN 2 0.0001
810 INFUSION RELATED REACTION 6 0.0001
811 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
812 BLOOD PRESSURE DECREASED 6 0.0001
813 BLOOD GLUCOSE INCREASED 17 0.0001
814 TACHYCARDIA 8 0.0001
815 EYE PRURITUS 3 0.0001
816 RASH PAPULAR 2 0.0001
817 ADVERSE DRUG REACTION 8 0.0001
818 OXYGEN SATURATION DECREASED 5 0.0001
819 FISTULA 1 0.0001
820 BLOOD CALCIUM DECREASED 1 0.0001
821 CHOLECYSTECTOMY 1 0.0001
822 LETHARGY 5 0.0001
823 SEIZURE 10 0.0001
824 PERICARDIAL EFFUSION 2 0.0001
825 ELECTROLYTE IMBALANCE 1 0.0001
826 EYELID OEDEMA 1 0.0001
827 ARRHYTHMIA 4 0.0001
828 BACTERAEMIA 1 0.0001
829 COMA 4 0.0001
830 THERAPY INTERRUPTED 6 0.0001
831 C-REACTIVE PROTEIN INCREASED 3 0.0001
832 BURSITIS 1 0.0001
833 ADRENAL INSUFFICIENCY 1 0.0001
834 ILL-DEFINED DISORDER 5 0.0001
835 ACCIDENTAL OVERDOSE 3 0.0001
836 CARDIOMEGALY 1 0.0001
837 APPLICATION SITE IRRITATION 1 0.0001
838 INTESTINAL OBSTRUCTION 3 0.0001
839 BRAIN OEDEMA 1 0.0001
840 HYPOPHAGIA 2 0.0001
841 ILLNESS 8 0.0001
842 UNRESPONSIVE TO STIMULI 2 0.0001
843 PNEUMONIA 25 0.0001
844 BLOOD CREATININE INCREASED 5 0.0001
845 GASTRITIS 2 0.0001
846 DEPRESSED MOOD 4 0.0001
847 DYSMENORRHOEA 1 0.0001
848 BRADYCARDIA 4 0.0001
849 EAR INFECTION 2 0.0001
850 EYE HAEMORRHAGE 1 0.0001
851 NEOPLASM MALIGNANT 5 0.0001
852 EXTRA DOSE ADMINISTERED 3 0.0001
853 NEUTROPHIL COUNT DECREASED 3 0.0001
854 PNEUMONITIS 2 0.0001
855 AKATHISIA 1 0.0001
856 ACUTE HEPATIC FAILURE 1 0.0001
857 CORONARY ARTERY OCCLUSION 1 0.0001
858 APPLICATION SITE RASH 1 0.0001
859 RESPIRATORY ARREST 2 0.0001
860 SEPSIS 8 0.0001
861 INTENTIONAL DOSE OMISSION 2 0.0001
862 BRONCHOSPASM 1 0.0001
863 VAGINAL HAEMORRHAGE 3 0.0001
864 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
865 MYOCARDIAL INFARCTION 12 0.0001
866 LIVER FUNCTION TEST ABNORMAL 2 0.0001
867 RESPIRATORY FAILURE 5 0.0001
868 LABORATORY TEST ABNORMAL 2 0.0001
869 CARDIOMYOPATHY 1 0.0001
870 LIVER DISORDER 3 0.0001
871 DRUG INEFFECTIVE 89 0.0001
872 URINARY INCONTINENCE 2 0.0001
873 RENAL INJURY 2 0.0001
874 COLON CANCER 1 0.0001
875 PULMONARY OEDEMA 3 0.0001
876 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
877 THERAPEUTIC RESPONSE DECREASED 4 0.0001
878 CHRONIC KIDNEY DISEASE 5 0.0001
879 INJECTION SITE RASH 2 0.0001
880 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
881 BONE DENSITY DECREASED 2 0.0001
882 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
883 INFLUENZA 7 0.0001
884 BLOOD POTASSIUM INCREASED 1 0.0001
885 LUNG DISORDER 3 0.0001
886 IMPAIRED HEALING 2 0.0001
887 CARDIAC ARREST 5 0.0001
888 DRUG LEVEL INCREASED 1 0.0001
889 VIRAL INFECTION 2 0.0001
890 BLOOD UREA INCREASED 1 0.0001
891 CELLULITIS 3 0.0001
892 TOXICITY TO VARIOUS AGENTS 10 0.0001
893 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
894 PRODUCT USE ISSUE 11 0.0001
895 HAEMATURIA 2 0.0001
896 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
897 AMENORRHOEA 1 0.0001
898 HYPERKALAEMIA 2 0.0001
899 INCORRECT DOSE ADMINISTERED 13 0.0001
900 HYPOXIA 2 0.0001
901 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
902 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
903 PRODUCT ADHESION ISSUE 2 0.0001
904 INFECTION 8 0.0001
905 DRUG EFFECT INCOMPLETE 2 0.0001
906 HYPERGLYCAEMIA 2 0.0001
907 PRODUCT DOSE OMISSION ISSUE 16 0.0001
908 ANAPHYLACTIC REACTION 3 0.0001
909 CONJUNCTIVITIS 1 0.0001
910 FRACTURE 1 0.0001
911 COLITIS 2 0.0001
912 FOOT FRACTURE 1 0.0001
913 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
914 DRUG PRESCRIBING ERROR 1 0.0001
915 ACUTE RESPIRATORY FAILURE 1 0.0001
916 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
917 COVID-19 9 0.0001
918 PLASMA CELL MYELOMA 2 0.0001
919 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
920 ABNORMAL BEHAVIOUR 2 0.0001
921 DRUG INTERACTION 8 0.0001
922 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
923 CYTOKINE RELEASE SYNDROME 1 0.0000
924 PSORIATIC ARTHROPATHY 2 0.0000
925 RHABDOMYOLYSIS 2 0.0000
926 DERMATITIS 1 0.0000
927 HYPOACUSIS 2 0.0000
928 SEPTIC SHOCK 2 0.0000
929 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
930 COLITIS ULCERATIVE 2 0.0000
931 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
932 THERAPY NON-RESPONDER 2 0.0000
933 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
934 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
935 INJURY 3 0.0000
936 PULMONARY EMBOLISM 4 0.0000
937 DRUG INTOLERANCE 4 0.0000
938 CEREBROVASCULAR ACCIDENT 7 0.0000
939 ENCEPHALOPATHY 1 0.0000
940 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
941 HYPOTENSION 8 0.0000
942 ACNE 3 0.0000
943 ACUTE KIDNEY INJURY 6 0.0000
944 HOSPITALISATION 6 0.0000
945 HAEMOGLOBIN DECREASED 4 0.0000
946 PSORIASIS 5 0.0000
947 ANHEDONIA 1 0.0000
948 PANCREATITIS 2 0.0000
949 BLOOD BILIRUBIN INCREASED 1 0.0000
950 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
951 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
952 OFF LABEL USE 31 0.0000
953 CONVULSION 2 0.0000
954 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
955 BLADDER CANCER 2 0.0000
956 CATARACT 2 0.0000
957 DEVICE ISSUE 3 0.0000
958 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
959 PLEURAL EFFUSION 2 0.0000
960 DRUG ADMINISTRATION ERROR 1 0.0000
961 CHOLELITHIASIS 1 0.0000
962 RENAL FAILURE 4 0.0000
963 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
964 HAEMORRHAGE 3 0.0000
965 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
966 UNDERDOSE 2 0.0000
967 DYSPNOEA EXERTIONAL 1 0.0000
968 ANAEMIA 5 0.0000
969 DISEASE PROGRESSION 3 0.0000
970 CARDIAC FAILURE 2 0.0000
971 CARDIAC FAILURE CONGESTIVE 2 0.0000
972 TREATMENT FAILURE 2 0.0000
973 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
974 ANGIOEDEMA 1 0.0000
975 BREAST CANCER 2 0.0000
976 FLUID RETENTION 1 0.0000
977 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
978 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
979 PLATELET COUNT DECREASED 2 0.0000
980 DEATH 16 0.0000
981 NO ADVERSE EVENT 3 0.0000
982 DEEP VEIN THROMBOSIS 1 0.0000
983 DEVICE DIFFICULT TO USE 1 0.0000
984 FEBRILE NEUTROPENIA 1 0.0000
985 OVERDOSE 3 0.0000
986 DRUG ABUSE 1 0.0000
987 ADVERSE EVENT 1 0.0000
988 EMOTIONAL DISTRESS 1 0.0000
989 DRUG DEPENDENCE 1 0.0000